Meta-signature LncRNAs serve as novel biomarkers for colorectal cancer: Integrated bioinformatics analysis, experimental validation and diagnostic evaluation

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Dai, Meiyu ^a   Chen, Xiaoli ^a   Mo, Shanying ^a   Li, Jinwan ^a   Huang, Zhizhuo ^a   Huang, Shifeng ^a   Xu, Junyi ^a   He, Baoyu ^a   Zou, Yan ^a   Chen, Jingfan ^a   Dai, Shengming ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG NONCODING RNA BLACAT1, HUMAN; LONG UNTRANSLATED RNA; RNA; TUMOR MARKER;

ADULT; AGED; BIOLOGY; BLOOD; CLINICAL TRIAL; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; MALE; MIDDLE AGED; VALIDATION STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; RNA, LONG NONCODING; RNA, NEOPLASM;

EID: 85017408964     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep46572     Document Type: Article

References (60)

1. Siegel, R., Ma, J., Zou, Z., Jemal, A. Cancer statistics, 2014. CA: A cancer journal for clinicians 64, 9-29, doi: 10. 3322/caac. 21208(2014).
2. Jemal, A., et al. Global cancer statistics. CA: A cancer journal for clinicians 61, 69-90, doi: 10. 3322/caac. 20107 (2011).
3. Chen, W., Zheng, R., Zeng, H., Zhang, S., He, J. Annual report on status of cancer in China, 2011. Chinese journal of cancerresearch = Chung-kuo yen cheng yen chiu 27, 2-12, doi: 10. 3978/j.issn. 1000-9604. 2015. 01. 06 (2015).
4. Zullig, L. L., et al. Colorectal Cancer Statistics From the Veterans Affairs Central Cancer Registry. Clinical colorectal cancer, doi:10. 1016/j.clcc. 2016. 04. 005 (2016).
5. Wapinski, O., Chang, H. Y. Long noncoding RNAs and human disease. Trends in cell biology 21, 354-361, doi: 10. 1016/j.tcb. 2011. 04. 001 (2011).
6. Sun, M., Kraus, W. L. From discovery to function: The expanding roles of long noncoding RNAs in physiology and disease. Endocrine reviews 36, 25-64, doi: 10. 1210/er. 2014-1034 (2015).
7. Kanduri, C. Long noncoding RNAs: Lessons from genomic imprinting. Biochimica et biophysica acta 1859, 102-111, doi: 10. 1016/j.bbagrm.2015.05. 006 (2016).
8. Zhu, X., et al. A long non-coding RNA signature to improve prognosis prediction of gastric cancer. Molecular cancer 15, 60, doi:10. 1186/s12943-016-0544-0 (2016).
9. Van Grembergen, O., et al. Portraying breast cancers with long noncoding RNAs. Science advances 2, e1600220, doi: 10. 1126/sciadv. 1600220 (2016).
10. Hu, Y., et al. A long non-coding RNA signature to improve prognosis prediction of colorectal cancer. Oncotarget 5, 2230-2242, doi:10. 18632/oncotarget. 1895 (2014).
11. Zhou, M., et al. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer. Journal of translational medicine 13, 231, doi: 10. 1186/s12967-015-0556-3 (2015).
12. Xue, Y., et al. Genome-wide analysis of long noncoding RNA signature in human colorectal cancer. Gene 556, 227-234, doi:10. 1016/j.gene.2014.11. 060 (2015).
13. Zhang, K., et al. Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner. Oncotarget 6, 537-546, doi: 10. 18632/oncotarget. 2681 (2015).
14. Zhou, M., et al. Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminatenonequivalent outcomes in patients with ovarian cancer. Oncotarget 7, 32433-32448, doi: 10. 18632/oncotarget. 8653 (2016).
15. Sun, J., et al. A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients. Scientific reports 5, 16553, doi: 10. 1038/srep16553 (2015).
16. Liu, T., Zhang, X., Yang, Y. M., Du, L. T., Wang, C. X. Increased expression of the long noncoding RNA CRNDE-h indicates a poorprognosis in colorectal cancer, and is positively correlated with IRX5 mRNA expression. OncoTargets and therapy 9, 1437-1448, doi:10. 2147/OTT. S98268 (2016).
17. Han, P., et al. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediatedregulation of Wnt/beta-catenin signaling. Molecular cancer 16, 9, doi: 10. 1186/s12943-017-0583-1 (2017).
18. Ohtsuka, M., et al. H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-beta-CateninSignaling in Colorectal Cancer. EBioMedicine 13, 113-124, doi: 10. 1016/j.ebiom.2016.10. 026 (2016).
19. Wu, K. F., et al. H19 mediates methotrexate resistance in colorectal cancer through activating Wnt/beta-catenin pathway. Experimental cell research 350, 312-317, doi: 10. 1016/j.yexcr.2016.12. 003 (2017).
20. Jing, S. Y., et al. Expression of long non-coding RNA CRNDE in glioma and its correlation with tumor progression and patientsurvival. European review for medical and pharmacological sciences 20, 3992-3996 (2016).
21. Zhang, T., et al. LncRNA H19 is overexpressed in glioma tissue, is negatively associated with patient survival, and promotes tumorgrowth through its derivative miR-675. European review for medical and pharmacological sciences 20, 4891-4897 (2016).
22. Szafron, L. M., et al. The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients. Oncotarget 6, 43897-43910, doi: 10. 18632/oncotarget. 6016 (2015).
23. Zhu, Z., et al. Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer. Internationaljournal of clinical and experimental pathology 8, 10082-10091 (2015).
24. Chen, Z., et al. LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384. American journal of cancer research 6, 2299-2309 (2016).
25. Yang, Z., et al. HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma afterCurative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus. Disease markers 2015, 191029, doi:10. 1155/2015/191029 (2015).
26. Zhou, M., et al. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinicallymolecular subtype and prognosis in diffuse large B cell lymphoma. Molecular cancer 16, 16, doi: 10. 1186/s12943-017-0580-4 (2017).
27. Zhou, M., et al. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkersfor early diagnosis of human pancreatic cancer. Oncotarget 7, 56383-56394, doi: 10. 18632/oncotarget. 10891 (2016).
28. Zhou, M., et al. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma. Oncotarget 7, 29720-29738, doi: 10. 18632/oncotarget. 8825 (2016).
29. Zhou, M., et al. Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNAbiomarkers in human ovarian cancer. Oncotarget 7, 12598-12611, doi: 10. 18632/oncotarget. 7181 (2016).
30. Zhou, X., Liu, J., Wang, W. Construction and investigation of breast-cancer-specific ceRNA network based on the mRNA andmiRNA expression data. IET systems biology 8, 96-103, doi: 10. 1049/iet-syb.2013.0025 (2014).
31. Xia, T., et al. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Scientific reports 4, 6088, doi: 10. 1038/srep06088 (2014).
32. Sala, D., Zorzano, A. Is TP53INP2 a critical regulator of muscle mass? Current opinion in clinical nutrition and metabolic care 18, 234-239, doi: 10. 1097/MCO. 0000000000000163 (2015).
33. Gan, Y., Herzog, E. L. MMP28 and macrophage polarization: Orchestrating the attack of the mac. Journal of leukocyte biology 95, 1-3, doi: 10. 1189/jlb. 0813423 (2014).
34. Sharma Saha, S., et al. Identification of genetic variation in the lncRNA HOTAIR associated with HPV16-related cervical cancerpathogenesis. Cellular oncology, doi: 10. 1007/s13402-016-0298-0 (2016).
35. She, K., et al. lncRNA-SNHG7 promotes the proliferation, migration and invasion and inhibits apoptosis of lung cancer cells byenhancing the FAIM2 expression. Oncology reports 36, 2673-2680, doi: 10. 3892/or.2016.5105 (2016).
36. Zhang, K., et al. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer. Cancer biomarkers: Section A of Diseasemarkers 17, 187-194, doi: 10. 3233/CBM-160630 (2016).
37. Lee, J. J., Kim, M., Kim, H. P. Epigenetic regulation of long noncoding RNA UCA1 by SATB1 in breast cancer. BMB reports 49, 578-583 (2016).
38. Hashad, D., Elbanna, A., Ibrahim, A., Khedr, G. Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a PromisingNovel Biomarker in Plasma of Patients with Gastric Cancer. Journal of clinical laboratory analysis 30, 1100-1105, doi: 10. 1002/jcla. 21987 (2016).
39. Shang, C., Guo, Y., Zhang, J., Huang, B. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapyresistance to adriamycin in gastric cancer. Cancer chemotherapy and pharmacology 77, 1061-1067, doi: 10. 1007/s00280-016-3029-3(2016).
40. Cui, J., et al. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-smallcell lung cancer. International journal of clinical and experimental pathology 8, 12400-12409 (2015).
41. Nie, W., et al. LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p. Cancer letters 371, 99-106, doi: 10. 1016/j.canlet.2015.11. 024 (2016).
42. Han, D., et al. Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruitingand binding to eIF4A3. Oncotarget 7, 22159-22173, doi: 10. 18632/oncotarget. 8063 (2016).
43. Bian, Z., et al. LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Scientific reports 6, 23892, doi: 10. 1038/srep23892 (2016).
44. Zheng, J., et al. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186. Oncotarget 6, 25339-25355, doi: 10. 18632/oncotarget. 4509 (2015).
45. Wang, Y., et al. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer letters367, 122-128, doi: 10. 1016/j.canlet.2015.03. 027 (2015).
46. Wang, W., Xing, C. Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis incolorectal cancer. Pathology, research and practice 212, 690-695, doi: 10. 1016/j.prp.2016.05. 003 (2016).
47. Thorenoor, N., et al. Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control andapoptosis in colorectal cancer. Oncotarget 7, 622-637, doi: 10. 18632/oncotarget. 5807 (2016).
48. Chen, X., Yan, C. C., Zhang, X., You, Z. H. Long non-coding RNAs and complex diseases: From experimental results tocomputational models. Briefings in bioinformatics, doi: 10. 1093/bib/bbw060 (2016).
49. Chen, X., You, Z. H., Yan, G. Y., Gong, D. W. IRWRLDA: Improved random walk with restart for lncRNA-disease associationprediction. Oncotarget 7, 57919-57931, doi: 10. 18632/oncotarget. 11141 (2016).
50. Chen, X., et al. HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction. Oncotarget 7, 65257-65269, doi: 10. 18632/oncotarget. 11251 (2016).
51. Chen, X., Huang, Y. A., Wang, X. S., You, Z. H., Chan, K. C. FMLNCSIM: Fuzzy measure-based lncRNA functional similaritycalculation model. Oncotarget 7, 45948-45958, doi: 10. 18632/oncotarget. 10008 (2016).
52. Chen, X., Yan, G. Y. Novel human lncRNA-disease association inference based on lncRNA expression profiles. Bioinformatics 29, 2617-2624, doi: 10. 1093/bioinformatics/btt426 (2013).
53. Ciasca, G., Papi, M., Minelli, E., Palmieri, V., De Spirito, M. Changes in cellular mechanical properties during onset or progressionof colorectal cancer. World journal of gastroenterology 22, 7203-7214, doi: 10. 3748/wjg. v22. i32. 7203 (2016).
54. Brown, D. G., et al. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer & metabolism 4, 11, doi: 10. 1186/s40170-016-0151-y (2016).
55. Shi, K. Q., et al. Hepatocellular carcinoma associated microRNA expression signature: Integrated bioinformatics analysis, experimental validation and clinical significance. Oncotarget 6, 25093-25108, doi: 10. 18632/oncotarget. 4437 (2015).
56. Chen, D., et al. Genome-wide analysis of long noncoding RNA (lncRNA) expression in colorectal cancer tissues from patients withliver metastasis. Cancer medicine 5, 1629-1639, doi: 10. 1002/cam4. 738 (2016).
57. Wang, C., et al. Long non-coding RNAs LOC285194, RP11-462C24. 1 and Nbla12061 in serum provide a new approach fordistinguishing patients with colorectal cancer from healthy controls. Oncotarget, doi: 10. 18632/oncotarget. 12220 (2016).
58. Weng, M., et al. Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer. Translational research: Thejournal of laboratory and clinical medicine, doi: 10. 1016/j.trsl.2016.10. 001 (2016).
59. Vosa, U., Kolde, R., Vilo, J., Metspalu, A., Annilo, T. Comprehensive meta-analysis of microRNA expression using a robust rankaggregation approach. Methods in molecular biology 1182, 361-373, doi: 10. 1007/978-1-4939-1062-5-28 (2014).
60. Kolde, R., Laur, S., Adler, P., Vilo, J. Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics 28, 573-580, doi: 10. 1093/bioinformatics/btr709 (2012).